TumCG Cancer Research Results

TumCG, Tumor cell growth: Click to Expand ⟱
Source:
Type:
Normal cells grow and divide in a regulated manner through the cell cycle, which consists of phases (G1, S, G2, and M).
Cancer cells often bypass these regulatory mechanisms, leading to uncontrolled proliferation. This can result from mutations in genes that control the cell cycle, such as oncogenes (which promote cell division) and tumor suppressor genes (which inhibit cell division).


Scientific Papers found: Click to Expand⟱
7718- IP6,    Inositol hexaphosphate inhibits growth, and induces G1 arrest and apoptotic death of prostate carcinoma DU145 cells: modulation of CDKI-CDK-cyclin and pRb-related protein-E2F complexes
- in-vitro, Pca, DU145
chemoPv↑, TumCG↓, TumCCA↑, P21↓, p27/CDKN1B↑, CDK2↓, CDK4↓, CDK6↓, cycE/CCNE↓, cycD1/CCND1↓, pRB↑, Apoptosis↑, cl‑PARP↑, Casp3↑,
7723- IP6,    Prostate cancer and inositol hexaphosphate: efficacy and mechanisms
- Review, Pca, NA
toxicity↓, AntiCan↑, TumCG↓, TumCCA↑, angioG↓,
7725- IP6,    Inositol hexaphosphate inhibits growth and induces differentiation of PC-3 human prostate cancer cells
- in-vitro, Pca, PC3
TumCG↓, HLA-I/II↑, Diff↑,
7646- IP6,  Ins,    Protection against cancer by dietary IP6 and inositol
- Review, Var, NA
*antiOx↑, TumCG↓, TumMeta↓, Imm↑, kidSt↓, LDL↓, TumCCA↑, TumCP↓, Diff↑, ChemoSen↑, QoL↑,
7690- IP6,  Ins,    Inositol Hexaphosphate (IP6) and Colon Cancer: From Concepts and First Experiments to Clinical Application
- Review, Colon, NA
AntiCan↑, Imm↑, antiOx↑, TumCP↓, Diff↑, TumCG↓, Synergy↑, P21↓, p27/CDKN1B↓, pRB↓, TumCCA↑, PI3K↓, Akt↓, PKCδ↓, RAS↓, ERK↓, NF-kB↓, Inflam↓, MMP9↓, IronCh↑, NK cell↑, selectivity↑, ChemoSen↑, chemoP↑, toxicity↓, Remission↑,
7692- IP6,    Inositol hexaphosphate inhibits constitutive activation of NF- kappa B in androgen-independent human prostate carcinoma DU145 cells
- in-vitro, Pca, DU145
NF-kB↓, IκB↑, TumCG↓,
7696- IP6,  Ins,    The Combination of Inositol Hexaphosphate and Inositol Inhibits Metastasis of Colorectal Cancer Cells by Upregulating Claudin 7
- vitro+vivo, Colon, SW48 - in-vitro, Colon, SW-620
AntiCan↑, CLDN7↑, EMT↓, E-cadherin↑, N-cadherin↓, Synergy↑, TumCG↓,
7704- IP6,    Inositol hexaphosphate hydrolysate competitively binds to AKT to inhibit the proliferation of colon carcinoma
- in-vitro, CRC, SW-620
TumCG↓, Akt↓, other↝,
1293- IP6,    Inositol Hexaphosphate Inhibits Growth and Induces G1 Arrest and Apoptotic Death of Androgen-Dependent Human Prostate Carcinoma LNCaP Cells
- vitro+vivo, Pca, LNCaP
TumCG↓, TumCCA↑, P21↑, CDK4↓, cycD1/CCND1↓, RB1↑, E2Fs↓,
8280- ISL,    ISL Induces Apoptosis and Autophagy in Hepatocellular Carcinoma via Downregulation of PI3K/AKT/mTOR Pathway in vivo and in vitro
- vitro+vivo, HCC, SMMC-7721 cell
tumCV↓, TumCP↓, Apoptosis↑, TumAuto↑, PI3K↓, Akt↓, mTOR↓, TumCG↓, LC3II↑, cl‑Casp3↑, eff↑,
7744- ISL,    Isoliquiritigenin suppresses fatty acid synthesis and cancer cell migration in anaplastic thyroid carcinoma through AMPK/SREBF1 pathway
- vitro+vivo, Thyroid, NA
AntiTum↑, TumCP↓, TumCMig↓, E-cadherin↑, N-cadherin↓, FASN↓, SREBP1/SREBF1↓, ATP↓, p‑AMPK↑, lipidLev↓, TumCG↓, lipoGen↓,
7746- ISL,    Isoliquiritigenin Inhibits the Growth of Colorectal Cancer Cells through the ESR2/PI3K/AKT Signalling Pathway
- vitro+vivo, CRC, SW480 - vitro+vivo, CRC, HCT116
AntiCan↑, tumCV↓, Apoptosis↑, TumCCA↑, TumCG↓, PI3K↓, Akt↓, p‑Akt↓, p‑GSK‐3β↓, CDK1↓, NF-kB↓, Bcl-2↓, ERβ/ESR2↑, BAX↑, Bax:Bcl2↑, ROS↑,
7756- ISL,    Dietary compound isoliquiritigenin inhibits breast cancer neoangiogenesis via VEGF/VEGFR-2 signaling pathway
- vitro+vivo, BC, MCF7 - vitro+vivo, BC, MDA-MB-231
AntiCan↑, VEGF↓, TumCI↓, TumCMig↓, Hif1a↓, TumCG↓, angioG↓, VEGFR2/KDR/Flk1↓, Apoptosis↑, toxicity↓, TumCCA↑, Inflam↓, ROS↑,
7790- ISL,    Dietary administration of the licorice flavonoid isoliquiritigenin deters the growth of MCF-7 cells overexpressing aromatase
- vitro+vivo, BC, MCF7
CYP19↓, TumCG↓, Weight∅, chemoP↓,
7777- ISL,    Isoliquiritigenin induces HMOX1 and GPX4-mediated ferroptosis in gallbladder cancer cells
- vitro+vivo, Gall, SGC996
TumCP↓, Ferroptosis↑, HO-1↑, GPx4↓, i-Iron↑, ROS↑, lipid-P↑, GSH/GSSG↓, TumCG↓, NRF2↑,
9253- ISO, IH,    Progress in the antitumor molecular mechanisms of Isorhamnetin
- Review, Var, NA
*antiOx↑, *Inflam↓, *AntiTum↑, TumCP↓, Apoptosis↑, TumCP↓, TumCI↓, TumCMig↓, ChemoSen↑, PI3K↓, Akt↓, TumCCA↑, MAPK↓, TumCG↓, CDK2↑, PPARγ↑, PTEN↓, CAIX/CA9↓, Casp8↑, Casp9↑, Casp3↑, ROS↑, ER Stress↑, UPR↑, BAX↑, Cyt‑c↑, cl‑PARP↑, Bcl-2↓, MMP↓, N-cadherin↓, Vim↓, Snail↓, E-cadherin↑, EMT↓, MMP2↓, MMP9↓,
9247- ISO, IH,  capec,    Isorhamnetin augments the anti-tumor effect of capecitabine through the negative regulation of NF-κB signaling cascade in gastric cancer
- vitro+vivo, GC, NA
tumCV↓, Synergy↑, NF-kB↓, TumCG↑,
9241- ISO, IH,    Isorhamnetin inhibited the proliferation and metastasis of androgen-independent prostate cancer cells by targeting the mitochondrion-dependent intrinsic apoptotic and PI3K/Akt/mTOR pathway
- in-vitro, Pca, DU145 - in-vitro, Pca, PC3
TumCG↓, LDH↓, selectivity↑, TumCMig?, TumCI?, MET↑, MMP2↓, MMP9↓, PI3K↓, Akt↓, mTOR↓, Bcl-2↓, BAX↑, Cyt‑c↑, cl‑PARP↑, E-cadherin↑, Vim↓, N-cadherin↓,
7812- ISQ,    Isoquercitrin promotes ferroptosis and oxidative stress in nasopharyngeal carcinoma via the AMPK/NF-κB pathway
- vitro+vivo, NPC, CNE1 - in-vitro, NPC, HNE1
tumCV↓, TumCP↓, ROS↑, lipid-P↑, NF-kB↓, MAPK↓, IL1β↓, TumCG↓, lipid-P↓, Ferroptosis↓, eff↓,
7810- ISQ,    Isoquercitrin Inhibits Lung Cancer Cell Growth Through Triggering Pyroptosis and Ferroptosis
- vitro+vivo, Lung, A549 - in-vitro, Nor, BEAS-2B
tumCV↓, selectivity↑, Apoptosis↑, NLRP3↑, Pyro↑, Ferroptosis↑, ROS↑, eff↓, Dose↝, TumCG↓,
7797- ISQ,    Isoquercitrin Suppresses Esophageal Squamous Cell Carcinoma (ESCC) by Inducing Excessive Autophagy and Promoting Apoptosis via the AKT/mTOR Signaling Pathway
- vitro+vivo, ESCC, KYSE-510 - in-vitro, ESCC, KYSE450
TumCG↓, Apoptosis↓, Casp↑, Bcl-2↓, EMT↓, TumAuto↑, ROS↑, Akt↓, PI3K↓, Catalase↓, SOD1↓, SOD2↓, eff↓,
7794- ISQ,    Isoquercitrin induces apoptosis and autophagy in hepatocellular carcinoma cells via AMPK/mTOR/p70S6K signaling pathway
- in-vitro, Liver, HepG2 - in-vitro, Liver, HUH7
tumCV↓, Apoptosis↑, TumAuto↑, AMPK↑, TumCG↓, ATG5↑, Beclin-1/ATG6↑, p‑mTOR↓, Casp3↑, cl‑PARP↑, Bax:Bcl2↑, LC3II↑, p62↓,
7792- ISQ,    Isoquercitrin suppresses colon cancer cell growth in vitro by targeting the Wnt/β-catenin signaling pathway
- in-vitro, CRC, SW48 - in-vitro, CRC, DLD1 - in-vitro, CRC, HCT116 - in-vitro, Nor, IEC-18
Wnt↓, TumCG↓, selectivity↑, β-catenin/ZEB1↓, TumCMig↓,
9177- ITCs,  SFN,    Dietary Isothiocyanates: Novel Insights into the Potential for Cancer Prevention and Therapy
- Review, Var, NA
CSCs↓, GutMicro↑, Bacteria↓, TumCCA↑, Apoptosis↑, TumAuto↑, angioG↓, TumCI↓, TumMeta↓, NRF2↑, Glycolysis↓, Wnt↓, β-catenin/ZEB1↓, HH↓, NOTCH↓, NK cell↑, EMT↓, angioG↓, BioAv↓, BioAv↑, AntiBio↑, Bacteria↓, HK2↓, PDH↓, OXPHOS↓, AKT1↓, ACC1↓, FASN↓, ACC-α↓, ACLY↓, SREBP1/SREBF1↓, OCT4↓, Nanog↓, YAP/TEAD↓, miR-21↓, miR-29b↓, ALDH1A1↓, miR-140↑, CD44↓, BMI1↓, miR-200c↑, TumCG↓, TumCI↓, TumCMig↓, E-cadherin↑, N-cadherin↓, Vim↓, α-SMA↓, Slug↓, Snail↓, Twist↓, DNAdam⇅, BioAv↓, ChemoSen↑,
9191- ITCs,  AITC,  BITC,  PEITC,  SFN  Molecular Targets of Isothiocyanates in Cancer: Recent Advances
- Review, Var, NA
Risk↓, TumCG↓, ROS↑, TumCCA↑, Apoptosis↑, Ingr?, chemoPv↑, P450↓, SXR↓, CYP3A4↓, NRF2↑, ARE↑, HO-1↑, p38↓, TrxR↑, Trx↑, NF-kB↓, AP-1↓, BioAv↑, Akt↓, STAT3↓, HDAC↓, VEGF↓, MMP2↓, Hif1a↓, CD31/PECAM-1↓, PI3K↓, PDK1 / PDPK1↓, mTOR↓, FOXO1↓, FOXO3↓, BIM↑, p27/CDKN1B↑, P21↑, HER2/EBBR2↓, EGFR↓, Bcl-xL↓, XIAP↓, ROS↓, Zeb1↓, Snail↓, E-cadherin↑, MMP2↓, MMP9↓, ROS↑, MMP↓, Casp↑, DNAdam↑, TumCCA↑, γH2AX↑, CSCs↓, OCT4↓, SOX2↓, Nanog↓, NOTCH2↑, selectivity↝, ETC↓, compI↓, compIII↓, OCR↓, Synergy↑, ChemoSen↑, RadioS↑, Synergy↑, Synergy↑, Synergy↑, Synergy↑, Synergy↑,
2178- itraC,    Itraconazole inhibits tumor growth via CEBPB-mediated glycolysis in colorectal cancer
- in-vivo, CRC, HCT116
TumCG↓, Glycolysis↓, CEBPB?, ENO1↓, LDHA↓, PKM2↓, GAPDH↓, ECAR↓, OCR↓,
7997- itraC,    Anti-fungal drug itraconazole exerts anti-cancer effects in oral squamous cell carcinoma via suppressing Hedgehog pathway
- vitro+vivo, SCC, NA
TumCP↓, TumCCA↑, Apoptosis↑, TumCI↓, TumCMig?, TumCG↓, Ki-67↓, HH?,
7998- itraC,    Itraconazole targets cell cycle heterogeneity in colorectal cancer
- vitro+vivo, CRC, NA
Wnt↓, TumCCA↑, TumCG↓, HH↓,
7999- itraC,    Itraconazole-Induced Inhibition on Human Esophageal Cancer Cell Growth Requires AMPK Activation
- vitro+vivo, ESCC, NA
AMPK↑, EGFR↓, PDGFRA↓, PDGFRB↓, Akt↓, TumCG↓,
8010- itraC,    Itraconazole induces apoptosis and cell cycle arrest via inhibiting Hedgehog signaling in gastric cancer cells
- vitro+vivo, GC, MKN45
TumCP↓, ChemoSen↑, TumCCA↑, Apoptosis↑, Gli1↓, TumCG↓, HH↓, Smo∅,
7993- itraC,    Preclinical evaluation of itraconazole in docetaxel-resistant prostate cancer xenograft models
- in-vivo, Pca, NA
TumCG∅, TumMeta↓, Ki-67↓, Gli1↓, HH↓,
8036- IVM,    Ivermectin inhibits the growth of ESCC by activating the ATF4-mediated endoplasmic reticulum stress-autophagy pathway
- in-vitro, ESCC, KYSE-30
*AntiP↑, AntiTum↑, ER Stress↑, TumAuto↑, ATF4↑, CHOP/DDIT3↝, TumCG↓, PERK↑, ROS↑, *toxicity↓, Ca+2↑,
8028- IVM,    Ivermectin as an Alternative Anticancer Agent: A Review of Its Chemical Properties and Therapeutic Potential
- Review, Var, NA
*BioAv↝, Apoptosis↑, TumCP↓, Wnt↓, β-catenin/ZEB1↓, TumCG↓, TumMeta↓, PI3K↓, Akt↓, mTOR↓, TumPF↓, CSCs↓, eff↑, ChemoSen↑, mtDam↑, MMP↓, ATP↓, ROS↑, NF-kB↓, BAX↑, Casp3↑, Casp9↑, ICD↑, Ki-67↓, PSA↓, YAP/TEAD↓,
8023- IVM,    Antitumor effects of the antiparasitic agent ivermectin via inhibition of Yes-associated protein 1 expression in gastric cancer
- vitro+vivo, GC, NA
YAP/TEAD↓, TumCG↓,
8022- IVM,    Antibiotic ivermectin preferentially targets renal cancer through inducing mitochondrial dysfunction and oxidative damage
- vitro+vivo, RCC, NA
AntiP↑, TumCP↓, Apoptosis↑, selectivity↑, TumCG↓, MMP↓, mitResp↓, ATP↓, ROS↑, eff↓,
8021- IVM,    The antiparasitic agent ivermectin induces chloride-dependent membrane hyperpolarization and cell death in leukemia cells
- vitro+vivo, AML, HL-60 - NA, lymphoma, U937 - NA, Pca, DU145
AntiP↑, TumCD↑, selectivity↑, TumCG↓, i-Chl↑, ROS↑, ChemoSen↑,
8049- IVM,    Ivermectin Induces Cytostatic Autophagy by Blocking the PAK1/Akt Axis in Breast Cancer
- vitro+vivo, BC, NA
*AntiP↑, AntiCan↑, AntiTum↑, PAK1↓, p‑Akt↓, Akt↓, mTOR↓, TumCG↓,
8050- IVM,  doxoR,    Repurposing Ivermectin to augment chemotherapy's efficacy in osteosarcoma
- in-vitro, OS, NA
ChemoSen↑, TumCG↑, TumCMig↓, Apoptosis↑,
1070- IVM,    Ivermectin accelerates autophagic death of glioma cells by inhibiting glycolysis through blocking GLUT4 mediated JAK/STAT signaling pathway activation
- vitro+vivo, GBM, NA
TumCG↓, LC3II↑, p62↓, ATP↓, Pyruv↓, GlucoseCon↑, HK2↓, PFK1↓, GLUT4↓, Glycolysis↓, JAK2↓, p‑STAT3↓, p‑STAT5↓,
7893- IVT,    Isovitexin (IV) induces apoptosis and autophagy in liver cancer cells through endoplasmic reticulum stress
- vitro+vivo, Liver, NA
TumCG↓, Apoptosis↑, BAX↑, cl‑Casp3↑, cl‑PARP↑, Cyt‑c↑, TumAuto↑, LC3II↑, ATG3↑, ATG5↑, Beclin-1/ATG6↑, ER Stress↑, IRE1↑, XBP-1↑, CHOP/DDIT3↑, GRP78/BiP↑, *chemoPv↑,
7910- IVT,    Isovitexin potentiated the antitumor activity of cisplatin by inhibiting the glucose metabolism of lung cancer cells and reduced cisplatin-induced immunotoxicity in mice
- vitro+vivo, Lung, A549 - vitro+vivo, Lung, H1975
TumCG↓, GlucoseCon↓, lactateProd↓, ATP↓, PKM2↓, ChemoSen↑,
8008- JG,    Juglone, isolated from Juglans mandshurica Maxim, induces apoptosis via down-regulation of AR expression in human prostate cancer LNCaP cells
- in-vitro, Pca, LNCaP
TumCG↓, MMP↓, Casp3↑, AR↓, PSA↓,
5099- JG,    Juglone induces ferroptosis in glioblastoma cells by inhibiting the Nrf2-GPX4 axis through the phosphorylation of p38MAPK
- vitro+vivo, GBM, LN229 - vitro+vivo, GBM, T98G
Ferroptosis↑, p‑MAPK↑, NRF2↓, GPx4↓, TumPF↓, Apoptosis↑, ROS↑, GSH↓, lipid-P↑, Ki-67↓, TumCG↓,
5117- JG,    https://pubmed.ncbi.nlm.nih.gov/31283929/
- vitro+vivo, Liver, NA
TumCG↓, TumCP↓, Apoptosis↑, TumAuto↑, AMPK↑, mTOR↑, P53↑, H2O2↑, ROS↑,
1918- JG,    ROS -mediated p53 activation by juglone enhances apoptosis and autophagy in vivo and in vitro
- in-vitro, Liver, HepG2 - in-vivo, NA, NA
TumCG↓, TumCP↓, Apoptosis↑, TumAuto↑, AMPK↑, mTOR↑, P53↑, H2O2↑, ROS↑, toxicity↝, p62↓, DR5↑, Casp8↑, PARP↑, cl‑Casp3↑,
1926- JG,    Mechanism of juglone-induced apoptosis of MCF-7 cells by the mitochondrial pathway
- in-vitro, BC, MCF7
TumCG↓, ROS↑, MMP↓, i-Ca+2↑, BAX↑, Bcl-2↓, Cyt‑c↑, Casp3?,
1921- JG,    Juglone induces ferroptotic effect on hepatocellular carcinoma and pan-cancer via the FOSL1-HMOX1 axis
- in-vitro, PC, NA - vitro+vivo, PC, NA
TumCG↓, Ferroptosis↑, ROS↑, Iron↑, lipid-P↑, MDA↑, GSH↓, FOSL1↑, HO-1↑,
8101- KAE,    Kaempferol inhibits cell proliferation and glycolysis in esophagus squamous cell carcinoma via targeting EGFR signaling pathway
- vitro+vivo, ESCC, KYSE150 - vitro+vivo, ESCC, Eca109
TumCCA↑, TumCP↓, Glycolysis↓, HK2↓, GlucoseCon↓, lactateProd↓, EGFR↓, TumCG↓, P21↑, Dose↝, Ki-67↓,
8066- KAE,  Rad,    Radiosensitization of non-small cell lung cancer by kaempferol
- in-vivo, Lung, A549
TumCG↓, selectivity↑, TumCCA↑, RadioS↑,
9006- L-THE,    Theanine from tea and its semi-synthetic derivative TBrC suppress human cervical cancer growth and migration by inhibiting EGFR/Met-Akt/NF-κB signaling
- vitro+vivo, Cerv, HeLa
TumCG↓, TumCMig↓, EZH2↓, TumCG↓, toxicity↓, Dose?, TumVol↓,

Showing Research Papers: 551 to 600 of 989
Prev Page 12 of 20 Next

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 989

Pathway results for Effect on Cancer / Diseased Cells:


NA, unassigned(tgid=0) ⓘ

NA↓, 1,   NA↑, 1,   NA↝, 1,  

Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↓, 2,   antiOx↑, 6,   antiOx⇅, 1,   ARE↑, 1,   Catalase↓, 5,   Catalase↑, 4,   ENOX2↓, 2,   Fenton↑, 7,   GPx↓, 3,   GPx↑, 4,   GPx4↓, 19,   GSH↓, 52,   GSH↑, 3,   i-GSH↓, 1,   GSH/GSSG↓, 5,   GSR↓, 1,   GSR↑, 1,   GSSG↓, 1,   GSTs↓, 1,   H2O2↓, 4,   H2O2↑, 10,   i-H2O2↑, 1,   mt-H2O2↑, 1,   HO-1↓, 8,   HO-1↑, 11,   hyperG↓, 1,   Iron↓, 2,   Iron↑, 11,   Iron∅, 1,   i-Iron↑, 3,   c-Iron↑, 1,   Keap1↑, 1,   lipid-P↓, 4,   lipid-P↑, 20,   MDA↓, 2,   MDA↑, 11,   NADH↓, 1,   NADHdeh?, 1,   NADPH/NADP+↓, 2,   NOX2↑, 1,   NQO1?, 1,   NQO1↓, 1,   NQO1↑, 3,   Nrf1↓, 1,   Nrf1↑, 1,   NRF2↓, 15,   NRF2↑, 16,   NRF2↝, 1,   ox-PrxI↑, 1,   RNS↑, 2,   ROMO1↑, 1,   ROS?, 3,   ROS↓, 21,   ROS↑, 274,   ROS⇅, 3,   ROS↝, 2,   ROS∅, 1,   i-ROS↑, 1,   mt-ROS↑, 9,   SOD↓, 5,   SOD↑, 4,   SOD1↓, 2,   SOD1↑, 1,   SOD2↓, 4,   SOD2↑, 6,   TAC↓, 3,   TBARS↓, 1,   Thiols↓, 1,   i-Thiols↓, 1,   TKT↝, 1,   TOS↑, 1,   Trx↓, 2,   Trx↑, 1,   Trx1↓, 2,   ox-Trx1↑, 1,   TrxR↓, 7,   TrxR↑, 1,   TrxR1↓, 3,   xCT/SLC7A11↓, 12,  

Metal & Cofactor Biology(tgid=2) ⓘ

Ferritin↓, 3,   Ferritin↑, 1,   FPN↝, 1,   FTH1↓, 3,   IronCh↑, 1,   LIP↑, 1,   NCOA4↑, 2,   Tf↑, 1,   TfR1/CD71↓, 1,   TfR1/CD71↝, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

CDC2↓, 3,   p‑CDC2↓, 1,   CDC25↓, 10,   CDC25↑, 2,   CDC25↝, 1,   compI↓, 2,   compIII↓, 1,   EGF↓, 2,   ETC↓, 8,   HSP60/HSPD1↓, 4,   HSP60/HSPD1↑, 1,   Insulin↓, 3,   mitResp↓, 7,   mitResp↑, 2,   mtDam?, 1,   mtDam↓, 2,   mtDam↑, 26,   OCR↓, 10,   OCR↑, 5,   OXPHOS↓, 5,   OXPHOS↑, 10,   mt-OXPHOS↓, 1,   PDH↓, 2,   PDH↑, 6,   p‑PDH↓, 1,   PGC-1α↓, 1,   PGC-1α↑, 1,   PHB↑, 1,   PINK1↑, 2,   SIRT3↑, 2,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

12LOX↓, 3,   5LO↓, 3,   ACC↓, 1,   ACC-α↓, 2,   ACC1↓, 1,   Acetyl-CoA↓, 1,   ACLY↓, 5,   ACSL4↑, 3,   Alanine↓, 1,   ALAT↓, 5,   ALAT∅, 1,   AMP↓, 1,   AMPK↓, 2,   AMPK↑, 23,   AMPK↝, 1,   p‑AMPK↑, 4,   ARG↓, 1,   ATGL/PNPLA2↓, 1,   ATP↓, 38,   ATP↑, 3,   i-ATP↑, 1,   Buty↑, 1,   CAIX/CA9↓, 1,   CAIX/CA9↑, 1,   cAMP↓, 1,   cAMP⇅, 1,   i-citrate↑, 1,   CRM↑, 3,   DHODH↓, 1,   ECAR↓, 7,   ECAR∅, 1,   ENO1↓, 3,   FABP4↑, 1,   FABP5/E-FABP↓, 1,   FASN↓, 7,   FDG↓, 1,   FFA/NEFA↓, 1,   G6PD↓, 1,   GALNT10↓, 1,   GAPDH↓, 4,   GLS↓, 1,   glucoNG↓, 1,   glucose↓, 2,   GlucoseCon↓, 26,   GlucoseCon↑, 3,   GlutMet↓, 1,   Glycine↓, 1,   Glycolysis↓, 57,   Glycolysis↑, 2,   GPI↓, 1,   GSK‐3β↓, 4,   GSK‐3β↑, 4,   p‑GSK‐3β↓, 2,   p‑GSK‐3β↑, 1,   HK2↓, 25,   HK2∅, 1,   HMG-CoA↓, 7,   HSL/LIPE↓, 1,   p‑HSL/LIPE↑, 1,   IDH1↑, 1,   KeyT↑, 1,   lactateProd↓, 29,   lactateProd↑, 2,   LDHA↓, 19,   LDHA∅, 1,   LDL↓, 2,   lipidLev↓, 1,   lipoGen↓, 2,   MATs↓, 1,   MCT4↓, 2,   MethCyc↓, 1,   NAD↓, 2,   NADPH↓, 1,   NADPH↑, 1,   NPC1L1↓, 1,   PA↑, 2,   PDK1 / PDPK1↓, 8,   PDKs↓, 4,   PFK↓, 4,   PFK1↓, 5,   PFKP↓, 3,   PKM1↑, 1,   PKM2↓, 21,   p‑PKM2↓, 1,   polyA↓, 1,   PPP↓, 2,   Pyruv↓, 3,   Pyruv↑, 1,   R5P↝, 1,   SCFAs↑, 1,   SIRT1↓, 8,   SIRT1↑, 3,   SREBF2↓, 1,   SREBP1/SREBF1↓, 4,   TCA↓, 2,   TCA↑, 2,   TPI↓, 1,   TS↓, 1,   Warburg↓, 14,   Warburg↑, 1,  

Cell Death(tgid=5) ⓘ

AIF↑, 11,   APAF1↑, 1,   Apoptosis↓, 12,   Apoptosis↑, 381,   Apoptosis∅, 2,   mt-Apoptosis↑, 1,   ASC↑, 1,   ASK1↑, 1,   BAD↓, 3,   BAD↑, 3,   Bak↑, 3,   BAX↓, 2,   BAX↑, 113,   BAX↝, 1,   Bax:Bcl2↑, 32,   Bcl-2?, 1,   Bcl-2↓, 150,   Bcl-2↑, 1,   Bcl-xL↓, 36,   Bcl-xL↑, 3,   BID↓, 1,   BID↑, 5,   cl‑BID↑, 1,   BIM↑, 6,   BNIP3↑, 1,   BNIP3↝, 1,   Casp↑, 38,   Casp↝, 1,   Casp1↓, 2,   Casp1↑, 1,   cl‑Casp1↑, 1,   Casp12↑, 1,   Casp3?, 1,   Casp3↓, 3,   Casp3↑, 134,   cl‑Casp3↓, 1,   cl‑Casp3↑, 52,   proCasp3↓, 1,   CASP4↑, 2,   Casp6↓, 1,   Casp6↑, 1,   Casp7↑, 17,   cl‑Casp7↑, 4,   Casp8↓, 1,   Casp8↑, 32,   cl‑Casp8↑, 11,   Casp9↓, 1,   Casp9↑, 65,   p‑Casp9↑, 1,   cl‑Casp9↓, 1,   cl‑Casp9↑, 12,   cFLIP↓, 2,   Cupro↑, 1,   Cyt‑c↓, 1,   Cyt‑c↑, 77,   Cyt‑c↝, 1,   cl‑Cyt‑c↑, 1,   Diablo↑, 1,   DR5↑, 11,   Endon↑, 1,   FADD↑, 3,   Fap1↓, 1,   Fas↓, 4,   Fas↑, 7,   FasL↓, 2,   FasL↑, 5,   Ferroptosis↓, 1,   Ferroptosis↑, 31,   GSDMC↑, 1,   GSDMD↑, 1,   cl‑GSDMD↑, 1,   cl‑GSDME↑, 3,   GSDME-N↑, 1,   HEY1↓, 2,   IAP1↓, 7,   IAP2/BIRC3↓, 3,   ICD↑, 2,   iNOS↓, 4,   Mcl-1↓, 17,   MDM2↓, 6,   MDM2↑, 1,   MLKL↑, 2,   p‑MLKL↓, 1,   MOMP↑, 2,   Necroptosis↑, 4,   necrosis↑, 6,   NOXA↑, 3,   p38↓, 5,   p38↑, 13,   p‑p38↓, 3,   p‑p38↑, 3,   PUMA↑, 3,   Pyro↑, 11,   RIP3↑, 2,   p‑RIP3↑, 2,   survivin↓, 48,   survivin↑, 1,   TNFR 1↑, 1,   TRAIL↑, 2,   TRAILR↑, 1,   TumCD↓, 2,   TumCD↑, 26,   TumCD∅, 1,   TUNEL↑, 1,   XIAP↓, 17,   YAP/TEAD↓, 10,   YAP/TEAD↑, 2,  

Kinase & Signal Transduction(tgid=6) ⓘ

ABL1↓, 1,   Akt↓, 117,   Akt↑, 6,   p‑Akt↓, 41,   p‑Akt↑, 1,   AKT1↓, 4,   BCAP↓, 1,   BRAF↓, 2,   BRAF↑, 1,   CaMKII ?, 1,   CaMKII ↓, 3,   CIP2A↓, 1,   cMET↓, 5,   CREB↓, 2,   p‑CREB↓, 1,   cSrc↓, 1,   DDIT4?, 1,   DYRK1B↓, 1,   EGFR↓, 29,   EGFR↝, 1,   p‑EGFR↓, 1,   ERK↓, 24,   ERK↑, 6,   ERK↝, 1,   p‑ERK↓, 15,   p‑ERK↑, 3,   e-ERK↑, 1,   FLT3↓, 1,   FOXD3↑, 1,   HER2/EBBR2↓, 10,   p‑HER2/EBBR2↓, 1,   HGF/c-Met↓, 3,   Hippo↑, 1,   IGF-1R↓, 4,   p‑IGF-1R↓, 1,   IGFR↓, 3,   p‑IGFR↓, 1,   IKKα↓, 8,   IKKα↑, 1,   p‑IKKα↓, 2,   IκB↑, 1,   p‑IκB↓, 2,   JAK↓, 4,   JAK1?, 1,   JAK1↓, 3,   p‑JAK1↓, 2,   JAK2↓, 13,   p‑JAK2↓, 4,   JNK↓, 3,   JNK↑, 15,   JNK↝, 1,   p‑JNK↓, 2,   p‑JNK↑, 3,   cl‑JNK↑, 1,   LIFR/CD118↓, 1,   MAPK↓, 18,   MAPK↑, 11,   p‑MAPK↑, 2,   MARK4↓, 1,   MEK↓, 3,   MEK↑, 1,   p‑MEK↓, 1,   mTOR↓, 64,   mTOR↑, 7,   p‑mTOR↓, 8,   p‑mTOR↑, 1,   mTORC2↓, 2,   mTORC2↑, 1,   NIK↓, 1,   OR13G1?, 1,   p‑p70S6↓, 2,   P70S6K↓, 4,   P70S6K↑, 1,   p‑P70S6K↓, 2,   p‑P70S6K↑, 1,   PDE3B↓, 1,   PDGFR-BB↓, 1,   PDGFRA↓, 3,   PDGFRB↓, 1,   PI3K↓, 79,   PI3K↑, 2,   PI3K↝, 1,   p‑PI3K↓, 6,   PI3K/Akt↓, 4,   PI3K/Akt↑, 1,   p‑PI3k/Akt/mTOR↓, 1,   PKA↓, 2,   p‑PKA↓, 1,   PKCδ↓, 5,   p‑PKCδ↓, 2,   PPP2R1A↑, 1,   PTEN↓, 3,   PTEN↑, 15,   PTK2B / PYK2↓, 1,   Raf↓, 3,   RAS↓, 5,   Rictor↓, 1,   RIP1↑, 1,   RSK2/RPS6KA3/p90RSK2↓, 1,   Sp1/3/4↓, 12,   Sp1/3/4↑, 1,   Src↓, 3,   STAT↓, 4,   STAT3↓, 64,   STAT3↑, 1,   STAT3↝, 1,   p‑STAT3↓, 16,   p‑STAT3↑, 2,   STAT4↑, 1,   STAT5↓, 2,   p‑STAT5↓, 1,   SYK↑, 1,   TSC2↑, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

ATF1↓, 1,   ATF2↓, 1,   ATF3↑, 2,   ATF4↑, 10,   BRD4↓, 1,   CBP↓, 1,   ChrMod↑, 2,   cJun↓, 3,   cJun↑, 2,   cMyc↓, 37,   cMyc↑, 1,   DNMT1↓, 6,   DNMT3A↓, 1,   DNMT3B↓, 2,   DNMTs↓, 5,   EZH2↓, 3,   FOXM1↓, 2,   FOXO1↓, 2,   FOXO1↑, 3,   FOXO3↓, 1,   FOXO3↑, 3,   FOXO3↝, 1,   p‑FOXO3↓, 1,   GATA3↓, 1,   H19↑, 1,   H3↓, 2,   H3↑, 1,   ac‑H3↑, 2,   H3K4↓, 1,   H3K9↓, 1,   H4↑, 1,   ac‑H4↑, 1,   HATs↓, 2,   HATs↑, 1,   HDAC↓, 27,   HDAC↑, 1,   HDAC1↓, 2,   HDAC2↓, 4,   HDAC3↓, 2,   HDAC4↓, 1,   HDAC6↓, 1,   HDAC8↓, 2,   HMTs↓, 1,   KLF2↓, 1,   KLF5↓, 1,   miR-106b↓, 1,   miR-122-5p↑, 1,   miR-133a-3p↑, 1,   miR-139-5p↑, 1,   miR-140↑, 1,   miR-141↑, 1,   miR-155↓, 1,   miR-199↓, 1,   miR-200b↑, 1,   miR-200c↑, 1,   miR-203↑, 1,   miR-205↑, 2,   miR-21↓, 3,   miR-22↑, 1,   miR-27a-3p↓, 2,   miR-29b↓, 1,   miR-29b↑, 1,   miR-30a-5p↑, 1,   miR-330-5p↑, 1,   miR-34a↓, 1,   miR-34a↑, 4,   miR-375↑, 1,   miR-486↑, 1,   miR-542↓, 1,   Myc↓, 5,   MYCN↑, 1,   OCT4↓, 15,   OLIG2↓, 1,   other?, 1,   other↓, 4,   other↑, 8,   other↝, 27,   PhotoS↑, 1,   SD↑, 1,   SOX2↓, 9,   SOX9↓, 2,   SUV39H↓, 7,   SUZ12↓, 1,   TCF-4↓, 1,   tumCV?, 1,   tumCV↓, 81,   tumCV∅, 2,  

Protein Folding & ER Stress(tgid=8) ⓘ

ATF6↑, 2,   CHOP/DDIT3↑, 18,   CHOP/DDIT3↝, 1,   eIF2α↑, 5,   p‑eIF2α↑, 6,   ER Stress↑, 39,   ERStress↑, 1,   GRP78/BiP↓, 1,   GRP78/BiP↑, 12,   GRP94↑, 1,   HSP27↓, 2,   HSP70/HSPA5↓, 1,   HSP70/HSPA5↑, 2,   HSP72↑, 1,   HSP90↓, 7,   HTRA↓, 2,   IRE1↑, 4,   NPL4↓, 1,   PDI↑, 1,   PERK↓, 1,   PERK↑, 8,   p‑PERK↑, 1,   Proteasome↓, 3,   UPR↓, 1,   UPR↑, 11,   XBP-1↑, 1,   XBP-1↝, 1,  

Autophagy & Lysosomes(tgid=9) ⓘ

ATG13↑, 1,   ATG3↓, 1,   ATG3↑, 1,   ATG5↑, 6,   ATG7↑, 1,   autoF↓, 1,   autolysosome↑, 1,   Beclin-1/ATG6↓, 2,   Beclin-1/ATG6↑, 13,   CTSB↓, 1,   CTSD↓, 1,   CTSL↑, 1,   LC3‑Ⅱ/LC3‑Ⅰ↑, 5,   LC3B↑, 3,   LC3B-II↑, 3,   LC3II↓, 1,   LC3II↑, 11,   LC3s↓, 1,   LC3s↑, 2,   lysosome↓, 1,   MitoP↑, 1,   p62↓, 7,   p62↑, 6,   PARK2↑, 1,   SESN2↑, 1,   TumAuto↓, 3,   TumAuto↑, 57,   TumAuto↝, 1,  

DNA Damage & Repair(tgid=10) ⓘ

ATM↑, 1,   p‑ATM↑, 1,   ATR↑, 1,   DFF45↓, 1,   DNAdam↑, 64,   DNAdam⇅, 1,   mt-DNAdam↑, 1,   DNArepair↓, 1,   DNArepair↑, 1,   hTERT/TERT↓, 3,   MGMT↓, 1,   NHEJ↓, 1,   p16↑, 1,   P53?, 1,   P53↓, 3,   P53↑, 65,   P53↝, 3,   P53∅, 1,   p‑P53↑, 6,   PARP↓, 2,   PARP↑, 14,   p‑PARP↑, 2,   cl‑PARP↑, 63,   PARP1↓, 2,   PARP1↑, 2,   cl‑PARP1↑, 2,   PCNA↓, 23,   SAPK↑, 1,   Telomerase↓, 5,   TOP1↓, 2,   TOP2↓, 4,   TOP2↑, 1,   TP53↑, 1,   TRF2↓, 1,   γH2AX↑, 9,   γH2AX↝, 1,   p‑γH2AX↑, 2,  

Cell Cycle & Senescence(tgid=11) ⓘ

ANAPC2↑, 1,   AURKB↓, 1,   AURKB↑, 1,   BRD4↓, 1,   CC(CDKs/cyclins)↑, 1,   CDK1↓, 15,   CDK1↑, 1,   CDK1↝, 1,   CDK1/2/5/9↓, 1,   CDK2↓, 17,   CDK2↑, 2,   p‑CDK2↓, 1,   CDK4↓, 27,   CDK4↑, 3,   CDK4/6↓, 1,   CDK6↓, 7,   CDK6↑, 3,   CDK8↓, 1,   cellSen↑, 1,   CHK1↓, 2,   CHK1↑, 1,   CHK1↝, 1,   Chk2↑, 2,   p‑Chk2↑, 1,   Cyc↓, 3,   cycA1/CCNA1↓, 6,   cycA1/CCNA1↑, 1,   CycB/CCNB1↓, 21,   CycB/CCNB1↝, 1,   cycD1/CCND1↓, 74,   cycD1/CCND1↑, 1,   cycE/CCNE↓, 9,   cycE/CCNE↑, 1,   cycE1↓, 2,   cycF↑, 1,   E2Fs↓, 4,   GADD45A↑, 2,   Ki-67↓, 57,   Ki-67↑, 1,   mitA↑, 2,   p19↑, 1,   P21↓, 3,   P21↑, 58,   p27/CDKN1B↓, 2,   p27/CDKN1B↑, 19,   PLK1↓, 1,   pRB↓, 1,   pRB↑, 1,   RB1↓, 1,   RB1↑, 1,   p‑RB1↓, 2,   cl‑RB1↓, 1,   Securin↓, 2,   TubPol↓, 2,   TumCCA↓, 7,   TumCCA↑, 256,   β-Tubulin↓, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

4E-BP1↓, 1,   4E-BP1↑, 1,   p‑4E-BP1↓, 1,   ALDH↓, 7,   ALDH1A1↓, 2,   ALDH1A3↓, 1,   Axin2↑, 1,   BMI1↓, 4,   BMP7/OP1↓, 1,   CD133↓, 12,   CD133↑, 1,   CD24↓, 4,   CD34↓, 2,   CEBPB?, 1,   cFos↓, 4,   CSCs↓, 49,   CSCs↑, 2,   CSCsMark↓, 1,   Diff↑, 13,   EP4/PTGER4↑, 1,   FGF↓, 1,   FOSL1↑, 1,   Gli↓, 1,   Gli1↓, 20,   Gli1∅, 1,   GTPBP4↓, 1,   HH?, 1,   HH↓, 20,   HMGCR↓, 2,   HMGCR↑, 1,   Id1↓, 1,   IGF-1↓, 10,   IGF-1↑, 1,   IGFBP3↓, 1,   IGFBP3↑, 2,   Ki-67↓, 57,   Ki-67↑, 1,   Let-7↑, 1,   LRP6↓, 2,   mTORC1↓, 6,   Nanog↓, 12,   Nestin↓, 1,   NOTCH↓, 8,   NOTCH↑, 1,   NOTCH1↓, 8,   NOTCH1↝, 1,   NOTCH2↑, 2,   NOTCH3↓, 3,   p300↓, 1,   Piezo1↑, 2,   PTCH1↓, 8,   PTCH2↓, 1,   Shh↓, 7,   Smo↓, 8,   Smo∅, 1,   STAT1↓, 1,   Sufu↓, 1,   Sufu↑, 1,   TAZ↓, 2,   TumCG?, 11,   TumCG↓, 962,   TumCG↑, 18,   TumCG⇅, 2,   TumCG↝, 3,   TumCG∅, 6,   TumCP↓, 214,   TumCP↑, 6,   Wnt↓, 27,   Wnt/(β-catenin)↓, 4,  

Migration(tgid=13) ⓘ

AGRN↓, 1,   AKR1C2↓, 1,   AntiAg↑, 2,   AP-1↓, 4,   AP-1↝, 1,   ARG1/2↑, 1,   CA↓, 2,   Ca+2↓, 2,   Ca+2↑, 25,   Ca+2↝, 2,   i-Ca+2↑, 4,   Cal1↑, 1,   Cav1↓, 1,   Cav1↑, 1,   CCAT1↓, 1,   CD11b↓, 1,   i-Chl↑, 1,   COL11A1↓, 1,   CTNNB1↓, 1,   E-cadherin↓, 2,   E-cadherin↑, 43,   E-cadherin↝, 1,   EMT?, 1,   EMT↓, 64,   EMT↝, 1,   EpCAM↓, 1,   FAK↓, 11,   FAK↑, 1,   Fibronectin↓, 2,   Galectin-9↓, 1,   GIT1↓, 1,   GLI2↓, 5,   ITGA5↓, 2,   ITGB1↓, 3,   LEF1↓, 2,   MALAT1↓, 2,   MET↑, 1,   MMP1↓, 3,   MMP13↓, 2,   MMP15↓, 1,   MMP2↓, 54,   proMMP2↓, 1,   MMP3↓, 2,   MMP7↓, 6,   MMP9↓, 71,   MMPs↓, 8,   MTA1↓, 1,   MUC1↓, 1,   MUC1-C↓, 1,   N-cadherin↓, 27,   N-cadherin↝, 1,   Na+↑, 2,   NCAM↓, 1,   NFAT↑, 1,   p‑p44↓, 1,   PAK1↓, 1,   PCBP1↓, 1,   PDGF↓, 1,   Rac1↓, 1,   RECK↑, 1,   Rho↓, 2,   ROCK1↓, 1,   Slug↓, 11,   p‑SMAD2↓, 1,   SMAD3↓, 1,   Snail↓, 18,   SPARC↑, 2,   talin↓, 1,   TET1↓, 1,   TGF-β↓, 7,   TGF-β1↓, 2,   TIMP1↑, 4,   TIMP2↑, 4,   TRIB3↑, 2,   TSP-1↑, 2,   TumCA↓, 3,   TumCI?, 2,   TumCI↓, 112,   TumCI↑, 2,   TumCMig?, 2,   TumCMig↓, 123,   TumCMig↑, 2,   TumMeta?, 1,   TumMeta↓, 91,   TumMeta↑, 5,   TumPF↓, 4,   Twist↓, 8,   TXNIP↓, 1,   TXNIP↑, 2,   uPA↓, 7,   uPAR↓, 2,   Vim↓, 28,   Zeb1↓, 8,   Zeb1↑, 1,   ZEB2↓, 1,   α-SMA↓, 2,   α-tubulin↓, 4,   ac‑α-tubulin↑, 1,   β-catenin/ZEB1↓, 38,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 89,   angioG↑, 2,   CD31/PECAM-1↓, 8,   CD31/PECAM-1↑, 1,   ECM/TCF↓, 3,   EGR1↑, 1,   EGR4↓, 1,   Endoglin↑, 1,   eNOS↓, 1,   HIF-1↓, 3,   Hif1a↓, 50,   Hif1a↑, 1,   Hif1a↝, 1,   NO↓, 5,   NO↑, 2,   VCAM-1↓, 3,   VEGF↓, 84,   VEGF↑, 2,   VEGFR1↓, 2,   VEGFR2/KDR/Flk1↓, 13,   VM↓, 1,  

Barriers & Transport(tgid=15) ⓘ

AQPs↓, 1,   BBB↑, 7,   CellMemb↓, 1,   CellMemb↑, 4,   CLDN1↓, 1,   CLDN7↑, 1,   EPR↑, 9,   GLUT1↓, 11,   GLUT1↑, 1,   GLUT2↓, 1,   GLUT3↓, 1,   GLUT3↑, 1,   GLUT4↓, 2,   IBI↑, 1,   K+↑, 1,   memfluid↓, 1,   MMP?, 1,   MMP↓, 134,   MMP↑, 5,   MPT↑, 4,   Na+↑, 2,   NHE1↓, 1,   OCLN↑, 1,   TRPM7↑, 2,   TRPV1↓, 1,   TRPV1↑, 1,   TRPV1↝, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

ALC∅, 1,   CCL20↑, 1,   CD155↓, 1,   CD25+↓, 2,   CD4+↓, 3,   CD4+↑, 10,   CD44↓, 18,   CD44↝, 1,   CD47↓, 1,   CD8+↑, 12,   cDC2↓, 2,   p‑cDC2↓, 2,   cGAS–STING↑, 1,   CLP↑, 1,   COX1?, 1,   COX2/PTGS2?, 1,   COX2/PTGS2↓, 31,   COX2/PTGS2↑, 2,   CXCc↓, 1,   CXCL1↓, 1,   CXCL12↓, 1,   CXCL9↓, 1,   CXCR4↓, 9,   DCells↑, 3,   DR4↑, 2,   DR6↑, 1,   FOXP3↓, 1,   FoxP3+↓, 2,   Gal-3↓, 2,   GM-CSF↓, 3,   HLA-I/II↑, 1,   HMGB1↓, 4,   HMGB1↑, 1,   ICAM-1↓, 8,   IFN-γ↓, 2,   IFN-γ↑, 3,   IL1↓, 5,   IL1↑, 2,   IL10↓, 2,   IL10↑, 2,   IL12↓, 1,   IL12↑, 4,   IL18↑, 2,   IL1β↓, 9,   IL1β↑, 1,   IL2↓, 3,   IL2↑, 3,   IL4↑, 1,   IL6?, 1,   IL6↓, 22,   IL6↑, 2,   IL8↓, 7,   Imm↑, 22,   Imm↝, 1,   Inflam↓, 27,   Inflam↝, 1,   LPS↓, 1,   pol-M1↑, 1,   M2 MC↓, 1,   M2 MC↑, 1,   pol-M2 MC↓, 2,   Macrophages↑, 1,   MCP1/CCL2↓, 2,   MDSCs↓, 1,   mPGES-1↓, 1,   MyD88↓, 1,   NAF1↓, 1,   NF-kB↓, 111,   NF-kB↑, 5,   NF-kB⇅, 1,   NF-kB↝, 1,   p‑NF-kB↓, 3,   NK cell↑, 8,   NLRP3↓, 2,   NLRP3↑, 3,   p50↓, 1,   p65↓, 7,   p‑p65↓, 4,   PD-1↓, 2,   PD-L1↓, 19,   PD-L2↓, 1,   PGE2↓, 9,   PSA↓, 12,   T-Cell↑, 8,   TCF↓, 3,   Th1 response↑, 1,   TILs↑, 2,   TIM-3↓, 2,   TIRAP↓, 1,   TLR4↓, 3,   TLR4↝, 1,   TNF-α?, 1,   TNF-α↓, 13,   TNF-α↑, 4,   TNFRSF25/DR3/APO3/LARD/TRAMP/WSL1↑, 1,   Treg lymp↓, 2,  

Cellular Microenvironment(tgid=17) ⓘ

ADAM17↓, 1,   GFAP↓, 1,   pH↓, 2,   pH↑, 3,   pH↝, 1,   e-pH↑, 10,   i-pH↓, 1,   i-pH↑, 1,   TAMS↓, 1,  

Synaptic & Neurotransmission(tgid=18) ⓘ

SYN1↑, 1,  

Protein Aggregation(tgid=19) ⓘ

BACE/β-secretase↓, 1,   XO↓, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

ACTH↓, 1,   AR↓, 18,   COMT↑, 1,   CYP11A1↓, 1,   CYP19↓, 1,   DHT↓, 1,   ER-α36↓, 1,   ER(estro)↓, 2,   ERα/ESR1↓, 2,   ERβ/ESR2↑, 2,   FGF21↓, 1,   GR↓, 1,   HSD3B↓, 1,   PPARα↑, 1,   PPARα↝, 1,   PPARγ↑, 2,   RANKL↓, 2,   SRD5A1↑, 1,   StAR↓, 1,   SXR↓, 1,   testos↓, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

ABC↓, 1,   ABCG2↓, 1,   BioAv↓, 27,   BioAv↑, 24,   BioAv↝, 11,   ChemoSen?, 1,   ChemoSen↓, 4,   ChemoSen↑, 155,   ChemoSen∅, 2,   CompStab↓, 2,   CompStab↑, 1,   CompStab↝, 2,   CYP1A1↓, 1,   CYP1A1↑, 1,   CYP3A4↓, 1,   DDS↑, 1,   Dose?, 4,   Dose↓, 6,   Dose↑, 7,   Dose⇅, 2,   Dose↝, 104,   Dose∅, 13,   DrugR↓, 1,   eff?, 1,   eff↓, 84,   eff↑, 107,   eff↝, 16,   eff∅, 2,   Half-Life↓, 6,   Half-Life↑, 2,   Half-Life↝, 8,   Half-Life∅, 2,   MDR1↓, 6,   MRP1/ABCC1↓, 3,   P-gp/ABCB1↓, 11,   P-gp/ABCB1↝, 1,   P-gp/ABCB1∅, 1,   P450↓, 2,   P450↑, 1,   RadioS?, 1,   RadioS↑, 44,   RadioS↝, 1,   selectivity?, 1,   selectivity↓, 3,   selectivity↑, 128,   selectivity↝, 1,   selectivity∅, 1,   Synergy↑, 100,   TET2↑, 1,  

Clinical Biomarkers(tgid=22) ⓘ

AFP↓, 1,   ALAT↓, 5,   ALAT∅, 1,   AR↓, 18,   ascitic↓, 2,   AST↓, 4,   AST∅, 1,   BG↓, 4,   BMD↑, 3,   BP↓, 1,   BRAF↓, 2,   BRAF↑, 1,   EGFR↓, 29,   EGFR↝, 1,   p‑EGFR↓, 1,   ERα/ESR1↓, 2,   EZH2↓, 3,   Ferritin↓, 3,   Ferritin↑, 1,   FOXM1↓, 2,   HER2/EBBR2↓, 10,   p‑HER2/EBBR2↓, 1,   hTERT/TERT↓, 3,   IL6?, 1,   IL6↓, 22,   IL6↑, 2,   KeyT↑, 1,   LDH↓, 8,   LDH↑, 2,   p‑LDH↓, 1,   Myc↓, 5,   PD-L1↓, 19,   PSA↓, 12,   PSADT↑, 1,   SUZ12↓, 1,   TG/TAG↓, 1,   TP53↑, 1,   TRIB3↑, 2,   Tumccf↓, 3,  

Functional Outcomes(tgid=23) ⓘ

AntiAge↑, 2,   AntiArt↑, 1,   AntiCan↓, 1,   AntiCan↑, 62,   AntiCan?, 1,   antiCG↓, 1,   antiNeop↑, 4,   antiNeop∅, 1,   AntiTum↑, 40,   Appetite↑, 1,   BowelM↑, 1,   breath↑, 1,   cachexia↓, 3,   cardioP↑, 7,   CardioT↓, 1,   chemoP↓, 1,   chemoP↑, 24,   chemoPv↑, 19,   ChemoSideEff↓, 7,   cognitive↑, 1,   fatigue∅, 1,   FTO↑, 1,   hepatoP↑, 5,   hepatoP∅, 1,   kidSt↓, 1,   motorD↑, 1,   neuroP↑, 5,   Obesity↓, 1,   OS↑, 62,   OS⇅, 1,   Pain↓, 5,   PDE4↓, 1,   QoL↑, 7,   QoL∅, 2,   radioP↑, 7,   Remission↑, 5,   Risk↓, 28,   Risk↑, 1,   Sleep↑, 1,   Strength↑, 4,   toxicity↓, 49,   toxicity↑, 4,   toxicity⇅, 1,   toxicity↝, 14,   toxicity∅, 9,   TumNum↓, 3,   TumVol↓, 38,   TumW↓, 22,   Weight↑, 4,   Weight∅, 10,  

Infection & Microbiome(tgid=24) ⓘ

AntiBio↑, 1,   AntiP↑, 2,   Bacteria↓, 3,   GutMicro↑, 13,   Sepsis↓, 1,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr?, 2,   Ingr↝, 8,  
Total Targets: 1168

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↓, 7,   antiOx↑, 50,   ARE↑, 1,   Catalase↑, 12,   DPPH↓, 1,   GPx↑, 12,   GPx1↑, 1,   GSH↓, 2,   GSH↑, 19,   GSR↑, 3,   GSTs↑, 6,   H2O2↓, 2,   HO-1↑, 11,   lipid-P↓, 14,   MDA↓, 11,   NQO1↑, 1,   NRF2↑, 16,   ROS↓, 52,   ROS↑, 4,   ROS∅, 2,   mt-ROS↓, 1,   SOD↑, 18,   SOD1↑, 1,   SOD2↓, 1,   TBARS↓, 1,   Trx↓, 1,   Trx↑, 1,  

Metal & Cofactor Biology(tgid=2) ⓘ

IronCh↑, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

EGF↓, 1,   ETC↝, 1,   mitResp↑, 1,   OCR↓, 1,   OXPHOS↑, 1,   SIRT3↑, 1,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

5LO↓, 5,   adiP↑, 1,   ALAT?, 1,   ALAT↓, 6,   AMPK↓, 1,   AMPK↑, 4,   ATP↓, 1,   ATP↑, 1,   ECAR∅, 1,   glucose↓, 3,   GlucoseCon↑, 3,   GSK‐3β↓, 1,   GSK‐3β↑, 1,   LDL↓, 6,   lipidLev↓, 1,   NAD↓, 1,   NADPH↓, 1,   PONs↓, 1,   SIRT1↑, 6,  

Cell Death(tgid=5) ⓘ

Apoptosis↓, 5,   Apoptosis↑, 1,   ASC↓, 1,   BAX↓, 3,   BAX↑, 1,   Bax:Bcl2↓, 1,   Bcl-2↓, 1,   Bcl-2↑, 1,   Casp↓, 1,   Casp1↓, 2,   Casp3↓, 4,   Casp3↑, 1,   cl‑Casp8↑, 1,   Casp9↓, 2,   Cyt‑c↓, 2,   Cyt‑c↑, 1,   Ferroptosis↑, 1,   iNOS↓, 7,   iNOS↑, 1,   necrosis↓, 1,   survivin↓, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt↓, 2,   p‑Akt↑, 1,   Akt2↓, 1,   CREB↑, 1,   p‑CREB↑, 1,   ERK↑, 2,   IKKα↓, 1,   JNK↓, 1,   JNK↑, 1,   MAPK↓, 2,   MAPK↑, 1,   mTOR↓, 2,   mTOR↑, 1,   PTEN↓, 1,   STAT↓, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

AntiThr↑, 3,   ATF4↓, 1,   cJun↓, 1,   cMyc↓, 1,   FOXO3↑, 1,   other?, 1,   other↓, 2,   other↑, 6,   other↝, 2,   tumCV↓, 1,  

Protein Folding & ER Stress(tgid=8) ⓘ

CHOP/DDIT3↓, 1,   HSP27↑, 1,   HSP70/HSPA5↑, 1,   HSPs↓, 1,  

Autophagy & Lysosomes(tgid=9) ⓘ

Beclin-1/ATG6↓, 1,   LC3II↓, 1,  

DNA Damage & Repair(tgid=10) ⓘ

DNAdam↓, 4,   P53↓, 2,   PCNA↓, 1,  

Cell Cycle & Senescence(tgid=11) ⓘ

CDK2↓, 1,   CDK4↓, 1,   cycD1/CCND1↓, 2,   cycE/CCNE↓, 1,   GADD34↓, 1,   P21↓, 2,   RB1↓, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

Diff↑, 1,   IGF-1↑, 1,   neuroG↑, 1,   TumCG↓, 5,   TumCG↑, 1,   TumCG∅, 1,   TumCP↓, 1,   tyrosinase↓, 1,  

Migration(tgid=13) ⓘ

AntiAg↑, 4,   AP-1↓, 2,   BACH1↓, 1,   Ca+2↓, 3,   Ca+2↑, 2,   Ca+2∅, 1,   i-Ca+2↓, 1,   EMT↓, 1,   MLC2/MYL9↝, 1,   MMP9↓, 1,   MMPs↓, 1,   Snail↑, 1,   TGF-β↓, 2,   TIMP1↓, 1,   TumCI↓, 1,   TumMeta↓, 1,   Twist↑, 1,   Vim↑, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 1,   angioG↑, 1,   HIF-1↓, 1,   Hif1a↓, 1,   Hif1a↑, 1,   HIF2a↑, 1,   NO↓, 5,   VCAM-1↓, 2,   VEGF↓, 1,  

Barriers & Transport(tgid=15) ⓘ

BBB↓, 1,   BBB↑, 3,   BBB↝, 2,   CellMemb↑, 1,   GLUT2↑, 1,   GLUT3↑, 1,   GLUT4↑, 2,   MMP↓, 1,   MMP↑, 2,   OCLN↝, 1,   TJ↑, 1,   TRPC1↓, 1,   TRPV1↑, 1,   ZO-1↑, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CD19↑, 1,   CD4+↑, 2,   CD8+↑, 1,   COX1↓, 3,   COX2/PTGS2↓, 13,   HMGB1↓, 1,   ICAM-1↓, 1,   IFN-γ↓, 2,   IFN-γ↑, 1,   IL1↓, 1,   IL10↓, 1,   IL10↑, 2,   IL12↓, 1,   IL17↓, 2,   IL1β↓, 7,   IL2↑, 1,   IL6↓, 14,   IL8↓, 2,   Imm↓, 1,   Imm↑, 5,   Inflam↓, 57,   Inflam↑, 1,   IRF3↓, 1,   MyD88↓, 1,   Neut↑, 1,   NF-kB↓, 15,   NK cell↑, 2,   NLRP3↓, 2,   NLRP3↑, 1,   PGE2↓, 5,   TLR2↓, 2,   TLR4↓, 5,   TNF-α↓, 13,   TNF-α↑, 1,   TRIF↓, 1,   VitD↑, 1,  

Cellular Microenvironment(tgid=17) ⓘ

pH↝, 1,  

Synaptic & Neurotransmission(tgid=18) ⓘ

5HT↓, 1,   5HT↑, 1,   Ach↑, 1,   AChE↓, 8,   AChE↑, 1,   AChE↝, 1,   BDNF↓, 1,   BDNF↑, 6,   ChAT↑, 1,   GABA↑, 1,   MAOA↓, 1,   NGF↑, 1,   TrkB↑, 1,   β-Endo↑, 1,  

Protein Aggregation(tgid=19) ⓘ

Aβ↓, 6,   XO↓, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

PPARα↝, 1,   PPARγ↓, 1,   PPARγ↑, 3,  

Drug Metabolism & Resistance(tgid=21) ⓘ

BioAv?, 1,   BioAv↓, 11,   BioAv↑, 24,   BioAv↝, 7,   BioEnh↑, 3,   CompStab↑, 1,   CYP3A2↓, 1,   Dose?, 2,   Dose⇅, 1,   Dose↝, 4,   eff↑, 4,   Half-Life↓, 3,   Half-Life↝, 3,   Half-Life∅, 1,   P450↓, 3,   selectivity↑, 3,   Synergy↑, 3,  

Clinical Biomarkers(tgid=22) ⓘ

ALAT?, 1,   ALAT↓, 6,   ALP↓, 1,   AST↓, 7,   BMD↑, 2,   BP↓, 3,   colonLen↑, 1,   CRP↓, 4,   hs-CRP↓, 1,   IL6↓, 14,   LDH↓, 2,   LDH↑, 1,   TC↓, 1,   VitD↑, 1,  

Functional Outcomes(tgid=23) ⓘ

Analgesic↑, 1,   AntiAge↑, 3,   antiAll↑, 3,   AntiArt↑, 4,   AntiCan↑, 6,   AntiDiabetic↑, 8,   AntiTum↑, 2,   cardioP↑, 27,   chemoP↑, 5,   chemoPv↑, 6,   cognitive↑, 12,   DCR∅, 1,   hepatoP↑, 20,   memory↑, 13,   motorD↑, 1,   neuroP↑, 36,   ORR∅, 1,   OS↑, 3,   Pain↓, 2,   PDE4↓, 1,   PFS∅, 1,   QoL↑, 1,   radioP↑, 2,   RenoP↓, 1,   RenoP↑, 4,   Stroke↓, 2,   toxicity↓, 40,   toxicity↑, 3,   toxicity↝, 7,   toxicity∅, 12,   Weight↓, 1,   Wound Healing↑, 1,  

Infection & Microbiome(tgid=24) ⓘ

AntiBio↑, 1,   AntiFungal↑, 2,   AntiP↑, 2,   AntiViral↑, 5,   Bacteria↓, 11,   GutMicro↑, 6,   Sepsis↓, 1,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr↑, 2,   Ingr↝, 5,  
Total Targets: 292

Scientific Paper Hit Count for: TumCG, Tumor cell growth
29 Curcumin
29 Magnetic Fields
19 Phenethyl isothiocyanate
17 Quercetin
17 Sulforaphane (mainly Broccoli)
17 Magnetic Field Rotating
14 Berberine
14 EGCG (Epigallocatechin Gallate)
13 Silver-NanoParticles
13 Chemotherapy
13 Shikonin
12 Vitamin C (Ascorbic Acid)
12 Magnolol
12 Bicarbonate(Sodium)
11 Alpha-Lipoic-Acid
11 Melatonin
11 Baicalein
11 Garcinol
11 phytic acid, Inositol hexakisphosphate
10 Benzyl isothiocyanate
10 Capsaicin
10 Apigenin (mainly Parsley)
10 chaetocin
10 Fisetin
9 Cucurbitacin
9 Silymarin (Milk Thistle) silibinin
9 Resveratrol
9 Dichloroacetate
9 Deguelin
9 Formononetin
9 Phenylbutyrate
8 Astragalus
8 Radiotherapy/Radiation
8 Artemisinin
8 salinomycin
8 diet FMD Fasting Mimicking Diet
8 Emodin
8 Gambogic Acid
8 Ginkgetin
8 Honokiol
8 Ivermectin
8 Matrine
8 Magnesium
8 Pterostilbene
8 Urolithin
7 Allyl isothiocyanate
7 Cisplatin
7 Allicin (mainly Garlic)
7 HydroxyCitric Acid
7 Ashwagandha(Withaferin A)
7 immunotherapy
7 Boron
7 Boswellia (frankincense)
7 Crocetin
7 Isoliquiritigenin
7 Lycopene
7 mebendazole
7 methylseleninic acid
6 Metformin
6 Betulinic acid
6 Chrysin
6 Coenzyme Q10
6 Gemcitabine (Gemzar)
6 diet Methionine-Restricted Diet
6 Sulfasalazine
6 Indole-3-carbinol
6 Inulin Prebiotic
6 itraconazole
6 Juglone
6 Rosmarinic acid
6 α-Santalol/Sandalwood oil
5 chitosan
5 doxorubicin
5 Paclitaxel/Taxol
5 Berbamine
5 Beta-Caryophyllene
5 Centella asiatica / Gotu kola → asiaticoside
5 Citric Acid
5 Diindolylmethane
5 Dandelion Root
5 Eugenol
5 Gallic acid
5 Graviola
5 isoquercitrin
5 Linalool
5 Luteolin
4 3-bromopyruvate
4 Fenbendazole
4 Astaxanthin
4 Atorvastatin
4 Dipyridamole
4 Brucea javanica
4 Butyrate
4 Caffeic Acid Phenethyl Ester (CAPE)
4 Cynaropicrin
4 Docosahexaenoic Acid
4 Disulfiram
4 Evodiamine
4 Flaxseed/Linseed
4 Genistein (soy isoflavone)
4 Hydrogen Gas
4 Hyperoside
4 Isobavachalcone
4 Inositol
4 Nimbolide
4 Marjoram (Origanum majorana)
4 Terpinen-4-ol / Tea Tree Oil
4 Piperine
4 Piperlongumine
4 Selenite (Sodium)
4 Thymoquinone
4 Vitamin K2
4 VitK3,menadione
4 Zyflamend
3 Caffeic acid
3 Diclofenac
3 Baicalin
3 Bufalin/Huachansu
3 brusatol
3 Bruteridin(bergamot juice)
3 NTP, Non-Thermal Plasma,Cold Atmospheric Plasma
3 Carvacrol
3 Celastrol
3 Chlorogenic acid
3 Selenium NanoParticles
3 Copper and Cu NanoParticles
3 Photodynamic Therapy
3 tamoxifen
3 Ellagic acid
3 eicosapentaenoic acid
3 Fucoidan
3 Geraniol
3 Ginger/6-Shogaol/Gingerol
3 Glabrescione B
3 Gossypol/AT-101
3 HydroxyTyrosol
3 MCT, metronomic chemo
3 Isorhamnetin
3 Licochalcone A
3 Licorice
3 Lemongrass Extract/Citral
3 SDG/lignans
3 Modified Citrus Pectin
3 Mangiferin
3 Niclosamide (Niclocide)
3 Patchouli Oil (Pogostemon cablin)
3 Propyl gallate
3 Plumbagin
3 Aflavin-3,3′-digallate
2 2-DeoxyGlucose
2 Auranofin
2 5-fluorouracil
2 Phyllanthus emblica/Emblica officinalis/Amla / Indian Gooseberry
2 Andrographis
2 Anethole/trans-Anethole
2 Fennel Oil/Foeniculum vulgare
2 Ascorbyl Palmitate
2 Biochanin A
2 Bifidobacterium
2 Bromelain
2 α-Bisabolol / Chamomile oil
2 Carnosic acid
2 Cinnamon
2 Cynara scolymus/Globe Artichoke/Artichoke Extract
2 Polyphenols
2 Chlorella (Chlorella vulgaris)
2 Cyclopamine
2 Oxygen, Hyperbaric
2 diet Short Term Fasting
2 D-limonene
2 Ginkgo biloba-EGb 761
2 ferumoxytol
2 Galloflavin
2 Ginkgo biloba
2 Ginkgolide B
2 Grapeseed extract
2 Hydroxycinnamic-acid
2 iodine
2 Isothiocyanates
2 Isovitexin
2 Kaempferol
2 Lutein
2 Methylene blue
2 Moringin
2 Methylsulfonylmethane
2 Mushroom Chaga, Inonotus obliquus
2 Mushroom Lion’s Mane, Hericium erinaceus
2 Mushroom Maitake
2 Oroxylin-A
2 Oleuropein
2 Orlistat
2 Phycocyanin
2 Psoralidin
2 Hyperthermia
2 EMF
2 Oxaliplatin
2 Spermidine
2 Ursolic acid
2 Vitexin
2 Whole Body Vibration
1 1,8-Cineole
1 Açaí, Euterpe oleracea
1 Anzaroot, Astragalus fasciculifolius Bioss
1 octreotide
1 Acetyl-l-carnitine
1 DTS(dibenzyl trisulphide) from Anamu
1 Angelica archangelica / Garden Angelica
1 Anti-oxidants
1 5-Aminolevulinic acid
1 Aloe anthraquinones
1 beta-glucans
1 temozolomide
1 Bacopa monnieri
1 Black Rice, Oryza sativa
1 Bullatacin
1 Caffeine
1 urea
1 Cat’s Claw
1 Cannabidiol
1 Celecoxib
1 Chocolate
1 Cranberry
1 Calorie Restriction Mimetics
1 Carvone
1 Bicalutamide
1 CUSP9
1 Dichloroacetophenone(2,2-)
1 Dasatinib/Phyrago
1 Bortezomib
1 Date Fruit Extract
1 diet Ketogenic
1 diet Plant based
1 Ormeloxifene (Centchroman)
1 Aspirin
1 Zinc
1 Echinacea
1 PXD, phenoxodiol
1 Sorafenib (brand name Nexavar)
1 Electrical Pulses
1 erastin
1 Eurycomanone
1 Flaxseed Oil
1 Shilajit/Fulvic Acid
1 Ginkgolic acids
1 Hibiscus sabdariffa
1 capecitabine
1 L-Theanine
1 Lactobacillus
1 probiotics
1 Laetrile B17 Amygdalin
1 Lapachol
1 Lasiodin
1 Lactoferrin/Talactoferrin
1 MBE, Maqui berry
1 MCT oil
1 Methyl Jasmonate
1 vp16, etoposide
1 Methylglyoxal
1 magnetic nanoparticles
1 Morin
1 Mistletoe/Viscum album Extracts
1 Naringin
1 Noscapine
1 Aromatherapy
1 Purple Corn / Purple Maize
1 Parthenolide
1 Broccoli
1 raloxifen
1 Salvia officinalis
1 Vorinostat
1 Selenium
1 irinotecan
1 Salvia miltiorrhiza
1 Saikosaponin B1 and D
1 Sutherlandioside D
1 cetuximab
1 Taurine
1 Tomatine
1 triptolide
1 Tumor Treating Fields
1 Turmerones
1 Usnic acid
1 Vitamin B1/Thiamine
1 Vitamin B5,Pantothenic Acid
1 Transarterial Chemoembolization
1 Walnut
1 γ-Tocotrienol
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:%  Target#:323  State#:%  Dir#:%
wNotes=0 sortOrder:rid,rpid

 

Home Page